Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan M Domchek

Showing results (171-180 of 361) with videos related to

Pageof 37
Sort By:
JCO Precision Oncology|August 3, 2023
Biallelic <i>BRCA</i> Loss and Homologous Recombination Deficiency in Nonbreast/Ovarian Tumors in Germline <i>BRCA1/2</i> CarriersDylane Wineland, Anh N Le, Ryan Hausler, et al.
BMC Medical Research Methodology|August 19, 2020
Comparison of up-front cash cards and checks as incentives for participation in a clinician survey: a study within a trialLydia E Pace, Yeonsoo S Lee, Nadine Tung, et al.
Science Translational Medicine|May 18, 2012
CD25 blockade depletes and selectively reprograms regulatory T cells in concert with immunotherapy in cancer patientsAndrew J Rech, Rosemarie Mick, Sunil Martin, et al.
Lung Cancer (Amsterdam, Netherlands)|May 5, 2023
Olaparib and durvalumab in patients with relapsed small cell lung cancer (MEDIOLA): An open-label, multicenter, phase 1/2, basket studyMatthew G Krebs, Jean-Pierre Delord, Thomas R Jeffry Evans, et al.
Public Health Genomics|February 5, 2025
Pediatric DTC Genetic Testing for Adult-Onset Inherited Cancer Risk: The Perspectives of High-Risk ParentsMadison K Kilbride, Beth N Peshkin, Jada G Hamilton, et al.
Oncotarget|March 1, 2018
Rapid detection of <i>BRCA1/2</i> recurrent mutations in Chinese breast and ovarian cancer patients with multiplex SNaPshot genotyping panelsAva Kwong, John C W Ho, Vivian Y Shin, et al.
Breast Cancer Research and Treatment|December 3, 2011
Lack of association between common single nucleotide polymorphisms in the TERT-CLPTM1L locus and breast cancer in women of African ancestryYonglan Zheng, Temidayo O Ogundiran, Clement Adebamowo, et al.
Nature Medicine|July 26, 2011
Variants at 6q21 implicate PRDM1 in the etiology of therapy-induced second malignancies after Hodgkin's lymphomaTimothy Best, Dalin Li, Andrew D Skol, et al.
The New England Journal of Medicine|May 28, 2015
Gene-panel sequencing and the prediction of breast-cancer riskDouglas F Easton, Paul D P Pharoah, Antonis C Antoniou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 8, 2017
A Phase I-II Study of the Oral PARP Inhibitor Rucaparib in Patients with Germline <i>BRCA1/2</i>-Mutated Ovarian Carcinoma or Other Solid TumorsRebecca Kristeleit, Geoffrey I Shapiro, Howard A Burris, et al.
Pageof 37

Showing results (171-180 of 361) with videos related to

Sort By:
Pageof 37
JCO Precision Oncology|August 3, 2023
Biallelic <i>BRCA</i> Loss and Homologous Recombination Deficiency in Nonbreast/Ovarian Tumors in Germline <i>BRCA1/2</i> CarriersDylane Wineland, Anh N Le, Ryan Hausler, et al.
BMC Medical Research Methodology|August 19, 2020
Comparison of up-front cash cards and checks as incentives for participation in a clinician survey: a study within a trialLydia E Pace, Yeonsoo S Lee, Nadine Tung, et al.
Science Translational Medicine|May 18, 2012
CD25 blockade depletes and selectively reprograms regulatory T cells in concert with immunotherapy in cancer patientsAndrew J Rech, Rosemarie Mick, Sunil Martin, et al.
Lung Cancer (Amsterdam, Netherlands)|May 5, 2023
Olaparib and durvalumab in patients with relapsed small cell lung cancer (MEDIOLA): An open-label, multicenter, phase 1/2, basket studyMatthew G Krebs, Jean-Pierre Delord, Thomas R Jeffry Evans, et al.
Public Health Genomics|February 5, 2025
Pediatric DTC Genetic Testing for Adult-Onset Inherited Cancer Risk: The Perspectives of High-Risk ParentsMadison K Kilbride, Beth N Peshkin, Jada G Hamilton, et al.
Oncotarget|March 1, 2018
Rapid detection of <i>BRCA1/2</i> recurrent mutations in Chinese breast and ovarian cancer patients with multiplex SNaPshot genotyping panelsAva Kwong, John C W Ho, Vivian Y Shin, et al.
Breast Cancer Research and Treatment|December 3, 2011
Lack of association between common single nucleotide polymorphisms in the TERT-CLPTM1L locus and breast cancer in women of African ancestryYonglan Zheng, Temidayo O Ogundiran, Clement Adebamowo, et al.
Nature Medicine|July 26, 2011
Variants at 6q21 implicate PRDM1 in the etiology of therapy-induced second malignancies after Hodgkin's lymphomaTimothy Best, Dalin Li, Andrew D Skol, et al.
The New England Journal of Medicine|May 28, 2015
Gene-panel sequencing and the prediction of breast-cancer riskDouglas F Easton, Paul D P Pharoah, Antonis C Antoniou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 8, 2017
A Phase I-II Study of the Oral PARP Inhibitor Rucaparib in Patients with Germline <i>BRCA1/2</i>-Mutated Ovarian Carcinoma or Other Solid TumorsRebecca Kristeleit, Geoffrey I Shapiro, Howard A Burris, et al.
Pageof 37